Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils.
Fiore
S
S
Hematology Division, Brigham and Women's Hospital, Boston, Massachusetts.
Romano
M
M
Serhan
C N
CN
D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D015936:Complement C5a / Q000494:pharmacology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology*; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000096:biosynthesis*; D015289:Leukotrienes / Q000096:biosynthesis*; D044045:Lipoxins; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D011994:Recombinant Proteins / Q000494:pharmacology; D015398:Signal Transduction; D013917:Thrombin / Q000494:pharmacology
D006893:Hydroxyeicosatetraenoic Acids; D015289:Leukotrienes; D044045:Lipoxins; D011994:Recombinant Proteins; C040527:lipoxin A4; D009240:N-Formylmethionine Leucyl-Phenylalanine; D015936:Complement C5a; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; C042651:lipoxin B4; D013917:Thrombin